Westgren M, Selbing A, Stangenberg M
Department of Obstetrics and Gynaecology, King Faisal Specialist Hospital, Riyadh, Saudi Arabia.
Br Med J (Clin Res Ed). 1988 Mar 26;296(6626):885-6. doi: 10.1136/bmj.296.6626.885.
Six patients with pregnancies of 19-31 weeks' duration showing evidence of erythroblastosis fetalis were treated with 25 fetal intracardiac blood transfusions. Complications related to the procedure occurred on five occasions in three patients. In two of the six patients the fetus died, but it was unlikely that death was related to the intracardiac transfusions. Fetal intracardiac blood transfusion may result in potentially severe complications but offers an alternative when transfusion cannot be performed into the umbilical cord.
6例妊娠19 - 31周、有胎儿成红细胞增多症证据的患者接受了25次胎儿心脏内输血治疗。与该操作相关的并发症在3例患者中出现了5次。6例患者中有2例胎儿死亡,但死亡不太可能与心脏内输血有关。胎儿心脏内输血可能会导致潜在的严重并发症,但在无法进行脐带输血时提供了一种替代方法。